Revision as of 12:06, 16 February 2012 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Saving copy of the {{drugbox}} taken from revid 477065977 of page Oxyphenbutazone for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEMBL'). |
Latest revision as of 18:08, 21 October 2024 edit JWBE (talk | contribs)Extended confirmed users10,126 edits removed Category:Phenols; added Category:4-Hydroxyphenyl compounds using HotCat |
Line 1: |
Line 1: |
|
|
{{Short description|Chemical compound}} |
|
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid of page ] with values updated to verified values.}} |
|
|
|
{{Infobox drug |
|
{{Drugbox |
|
|
| Verifiedfields = changed |
|
| Verifiedfields = changed |
|
| verifiedrevid = 462267573 |
|
| verifiedrevid = 477171011 |
|
| IUPAC_name = (''RS'')-4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione |
|
| IUPAC_name = (''RS'')-4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione |
|
| image = oxyphenbutazone.png |
|
| image = oxyphenbutazone.svg |
|
| width = 250px |
|
| width = 250px |
|
|
| chirality = ] |
|
| imagename = 1 : 1 mixture (racemate) |
|
|
|
<!--Clinical data-->| tradename = Tandearil, Tanderil |
|
| drug_name = Oxyphenbutazone |
|
|
⚫ |
| Drugs.com = {{drugs.com|international|oxyphenbutazone}} |
|
⚫ |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
⚫ |
| pregnancy_US = <!-- A / B / C / D / X --> |
|
|
| legal_US_comment = Withdrawn |
|
⚫ |
| legal_UK = Withdrawn |
|
|
| legal_AU = Withdrawn |
|
⚫ |
<!--Identifiers-->| CAS_number_Ref = {{cascite|correct|??}} |
|
⚫ |
| CAS_number = 129-20-4 |
|
⚫ |
| ATC_prefix = M01 |
|
⚫ |
| ATC_suffix = AA03 |
|
⚫ |
| ATC_supplemental = {{ATC|M02|AA04}} {{ATC|S01|BC02}} |
|
⚫ |
| PubChem = 104811 |
|
⚫ |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
⚫ |
| DrugBank = DB03585 |
|
⚫ |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
⚫ |
| ChemSpiderID = 94610 |
|
⚫ |
| UNII_Ref = {{fdacite|correct|FDA}} |
|
⚫ |
| UNII = A7D84513GV |
|
⚫ |
| KEGG_Ref = {{keggcite|correct|kegg}} |
|
⚫ |
| KEGG = D08324 |
|
⚫ |
| ChEBI_Ref = {{ebicite|changed|EBI}} |
|
|
| ChEBI = 76258 |
|
|
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|
|
| ChEMBL = 1228 |
|
|
<!--Chemical data-->| C = 19 |
|
|
| H = 20 |
|
|
| N = 2 |
|
|
| O = 3 |
|
⚫ |
| smiles = O=C2N(c1ccc(O)cc1)N(C(=O)C2CCCC)c3ccccc3.O |
|
⚫ |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
⚫ |
| StdInChI = 1S/C19H20N2O3.H2O/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15;/h4-8,10-13,17,22H,2-3,9H2,1H3;1H2 |
|
⚫ |
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
⚫ |
| StdInChIKey = CNDQSXOVEQXJOE-UHFFFAOYSA-N |
|
⚫ |
}} |
|
|
|
|
|
|
'''Oxyphenbutazone''' is a ] (NSAID).<ref>{{cite journal | vauthors = Singh N, Jabeen T, Somvanshi RK, Sharma S, Dey S, Singh TP | title = Phospholipase A2 as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDS): crystal structure of the complex formed between phospholipase A2 and oxyphenbutazone at 1.6 A resolution | journal = Biochemistry | volume = 43 | issue = 46 | pages = 14577–83 | date = November 2004 | pmid = 15544328 | doi = 10.1021/bi0483561 }}</ref> It is a ] of ].<ref>{{cite journal | vauthors = Matthews NS, Peck KE, Taylor TS, Mealey KL | title = Pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in miniature donkeys | journal = American Journal of Veterinary Research | volume = 62 | issue = 5 | pages = 673–5 | date = May 2001 | pmid = 11341383 | doi = 10.2460/ajvr.2001.62.673 | doi-access = free }}</ref> |
|
<!--Clinical data--> |
|
|
| tradename = |
|
⚫ |
| Drugs.com = {{drugs.com|international|oxyphenbutazone}} |
|
⚫ |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
⚫ |
| pregnancy_US = <!-- A / B / C / D / X --> |
|
|
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 --> |
|
⚫ |
| legal_UK = <!-- GSL / P / POM / CD --> |
|
|
| legal_US = <!-- OTC / Rx-only --> |
|
|
|
|
|
|
|
It was withdrawn from markets worldwide in mid-1980s due to bone marrow suppression and the risk of ].<ref name=Fung-2001>{{cite journal| vauthors = Fung M, Thornton A, Mybeck K, Wu JH, Hornbuckle K, Muniz E |title=Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999 |journal=Therapeutic Innovation & Regulatory Science |date= January 2001 |volume=35 |issue=1 |pages=293–317 |doi=10.1177/009286150103500134 |s2cid=73036562 }}</ref><ref>{{cite journal | vauthors = Biron P | title = Withdrawal of oxyphenbutazone: what about phenylbutazone? | journal = CMAJ | volume = 134 | issue = 10 | pages = 1119–20 | date = May 1986 | pmid = 3697857 | pmc = 1491052 }}</ref> |
|
<!--Identifiers--> |
|
|
|
|
|
| CASNo_Ref = {{cascite|correct|CAS}} |
|
|
|
In '']'', the word "oxyphenbutazone" is the present highest scoring word resulting in 1,780 points based on the ] of 2006.<ref>{{cite web |last=Wood |first=Dave |name-list-style=vanc |date=22 May 2008 |title=Record for the Highest Scoring Scrabble Move |url=https://www.scrabulizer.com/blog/post/3#blog_post_break |url-status=live |archive-url=https://web.archive.org/web/20230511235136/https://www.scrabulizer.com/blog/post/3 |archive-date=11 May 2023 |work=Scrabulizer}}</ref> |
⚫ |
| CAS_number_Ref = {{cascite|correct|??}} |
|
|
|
|
⚫ |
| CAS_number = 129-20-4 |
|
|
|
== References == |
⚫ |
| ATC_prefix = M01 |
|
|
|
{{reflist}} |
⚫ |
| ATC_suffix = AA03 |
|
|
|
|
⚫ |
| ATC_supplemental = {{ATC|M02|AA04}} {{ATC|S01|BC02}} |
|
|
|
{{Anti-inflammatory and antirheumatic products}} |
⚫ |
| PubChem = 104811 |
|
|
|
{{Topical products for joint and muscular pain}} |
⚫ |
| DrugBank_Ref = {{drugbankcite|changed|drugbank}} |
|
|
|
|
⚫ |
| DrugBank = DB03585 |
|
|
|
] |
⚫ |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
|
|
] |
⚫ |
| ChemSpiderID = 94610 |
|
|
|
] |
⚫ |
| UNII_Ref = {{fdacite|correct|FDA}} |
|
|
|
] |
⚫ |
| UNII = A7D84513GV |
|
|
|
|
⚫ |
| KEGG_Ref = {{keggcite|correct|kegg}} |
|
|
|
|
⚫ |
| KEGG = D08324 |
|
|
|
{{musculoskeletal-drug-stub}} |
⚫ |
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|
|
| ChEMBL = <!-- blanked - oldvalue: 1228 --> |
|
|
| C=19 | H=20 | N=2 | O=3 |
|
|
| molecular_weight = 324.379 g/mol |
|
⚫ |
| smiles = O=C2N(c1ccc(O)cc1)N(C(=O)C2CCCC)c3ccccc3.O |
|
|
| InChI = 1/C19H20N2O3.H2O/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15;/h4-8,10-13,17,22H,2-3,9H2,1H3;1H2 |
|
|
| InChIKey = CNDQSXOVEQXJOE-UHFFFAOYAR |
|
⚫ |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
⚫ |
| StdInChI = 1S/C19H20N2O3.H2O/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15;/h4-8,10-13,17,22H,2-3,9H2,1H3;1H2 |
|
⚫ |
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
⚫ |
| StdInChIKey = CNDQSXOVEQXJOE-UHFFFAOYSA-N |
|
⚫ |
}} |
|